Learning Objectives:

  1. Update the audience on the prevalence and forms of genetic Parkinson's disease 
  2. Provide a brief review of genetically targeted experimental therapeutics in PD 
  3. Provide update on the commercial and research venues for PD genetic testing 
Session date: 
02/04/2021 - 7:30am to 8:30am CST
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: